We’re sharing our industry knowledge and expertise with you in fun and easy reads. Check back each month to see what’s new.
Today marks a pivotal moment for the future of rotator cuff repair. Integrity Orthopaedics is proud to announce our acquisition by Smith+Nephew (LSE: SN, NYSE: SNN), a global medical technology leader. This strategic partnership will accelerate the reach of our novel Tendon Seam™ system, helping surgeons and patients worldwide achieve better outcomes in sports medicine and regenerative technology. Link: Read the full press release
Second-quarter venture capital investments are up nearly 85% compared to last year, a recent low for funding of med-tech companies in the U.S. Burl Gilyard Star Tribune August 5th at 2:31 PM CDT Endogenex CEO Stacey Pugh holds the ReCET medical device, a catheter used for treatment of Type 2 diabetes, at the company’s Plymouth headquarters. (Renée Jones Schneider / Star Tribune)
Integrity Orthopaedics Announces Closure of Series B Financing Minneapolis, MN (April 30, 2024) – Integrity Orthopaedics, Inc., a company pioneering next generation solutions for soft tissue repair, has successfully closed on a Series B financing of $20.6 million. The financing was co-led by Piper Sandler Merchant Banking and an undisclosed existing investor. The company intends to use the capital to
Integrity Orthopaedics is pleased to announce that it is now part of Smith+Nephew, the global medical technology company and a leader in sports medicine and regenerative technology.
For more information please read the Smith+Nephew press release here:
For more information, the Smith and Nephew Privacy Notice can be viewed here.
